Clinical Trials Directory

Trials / Unknown

UnknownNCT03914651

CLBR Per Initial Cycle With Different Starting Dose in Aged Patients With Poor Ovarian Reservation: 300IU Versus 150IU

Comparison of Cumulative Live Birth Rate Per Initial Cycle Between 300 IU and 150IU Starting Dose of rFSH Among Aged Patients With Poor Ovarian Reservation: a Randomized Controlled Trail

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
260 (estimated)
Sponsor
Reproductive & Genetic Hospital of CITIC-Xiangya · Academic / Other
Sex
Female
Age
35 Years – 42 Years
Healthy volunteers
Not accepted

Summary

Among aged patients with poor ovarian reservation(defined as age 35 to 42 years; antral follicle count(AFC)≤ 5 or anti-mullerian hormone(AMH)≤ 1.2 ng/ml), cumulative live birth rate(CLBR) and time to live birth(TTLB) of the first stimulation cycle were compared between a starting dose of 300IU or 150IU rFSH in controlled ovarian stimulation with gonadotropin-releasing hormone(GnRH)antagonist protocol. This study is a prospective randomized controlled trial.

Conditions

Interventions

TypeNameDescription
DRUG300IU rFSH Gonal-F® starting dose during controlled ovarian stimulationOn menstrual cycle day 2 or day 3, 300IU rFSH Gonal-F® will be administrated daily till the day of trigger. The dosage of rFSH can be adjusted only if there is a risk of ovarian hyperstimulation syndrome(OHSS).
DRUG150IU rFSH Gonal-F® starting dose during controlled ovarian stimulationOn menstrual cycle day 2 or day 3, 150IU rFSH Gonal-F® will be administrated daily till the day of trigger. The dosage of rFSH can be adjusted only if there is a risk of OHSS or insufficient follicular growth.

Timeline

Start date
2019-04-23
Primary completion
2022-12-30
Completion
2022-12-30
First posted
2019-04-16
Last updated
2022-01-12

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03914651. Inclusion in this directory is not an endorsement.